What is FP7?

The Framework Programme (FP) is the European Union's main instrument for funding research and development. The FP is proposed by the European Commission and adopted by Council and the European Parliament following a co-decision procedure. FPs have been implemented since 1984 and cover a period of five years with the last year of one FP and the first year of the following FP overlapping. The current FP is FP6, which will be running up to the end of 2006.

It has been proposed for FP7, however, to run for seven years. It will be fully operational as of 1 January 2007 and will expire in 2013. It is designed to build on the achievements of its predecessor towards the creation of the European Research Area, and carry it further towards the development of the knowledge economy and society in Europe.

In the Commission's proposals for the Seventh Framework Programme to the European Parliament and the Council of 6 April 2005, the Commission proposed that the maximum overall amount for Community financial participation in the EC Seventh Framework Programme should be EUR 72 726 million for the period 2007 - 2013. For nuclear research and training activities carried out under the Euratom treaty EUR 3092 million are foreseen for 2007-2011.

On the basis of the first results of the debate on the present proposals, the Commission presented proposals for the Specific Programmes and for the "Rules for Participation" in the Framework Programme to the Council and the European Parliament in the second half of 2005. The key milestones towards FP7 are explained in the FP7 roadmap section.

For further information, please visit:
European Commission FP7 Home

Most Popular Now

Early Warning System for Intensive Care …

Life-threatening situations occur time and again in an intensive care unit. To make sure that doctors can intervene in time, a team at the German Heart Center Berlin (DHZB) has...

Virtual Reality could Help to Reduce Pai…

We all feel physical pain in different ways, but people with nerve injuries often have a dysfunctional pain suppression system, making them particularly prone to discomfort. Now researchers have uncovered that...

Philips Partners with Orbita to Develop …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Orbita Inc., an innovative provider of conversational artificial intelligence (AI) solutions for healthcare, announced a partnership agreement...

CliniSys Group Creates Single Brand for …

CliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website. The move creates a unified identity for CliniSys...

East Lancashire Signs Deal for Early War…

Thousands of NHS professionals across five hospitals in East Lancashire are to benefit from early warning technology that will help them detect and swiftly respond to deteriorating patients in need...

FDA Grants Oxehealth Vital Signs De Novo…

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision, the...

Telemedicine Improves Access to High-Qua…

The American Academy of Sleep Medicine recently published an update on the use of telemedicine for the diagnosis and treatment of sleep disorders to reflect lessons learned from the transition...

DMEA 2021: Digital Health. 100 % Virtual…

7 - 11 June 2021, Berlin, Germany. An entire week dominated by digital healthcare! With that in mind, early in June DMEA 2021 will be kicking off with a wide range...

Philips and NHS Implement the First Regi…

Royal Philips (NYSE: PHG, AEX: PHIA), announced it has supported the NHS' Cheshire and Merseyside consortium [1] to become the first regional hub supplying the United Kingdom's National COVID-19 Chest...

Child Brain Tumours can be Classified by…

Diffusion weighted imaging and machine learning can successfully classify the diagnosis and characteristics of common types of paediatric brain tumours a UK-based multi-centre study, including WMG at the University of...

AI could Crack the Language of Cancer an…

Powerful algorithms used by Netflix, Amazon and Facebook can 'predict' the biological language of cancer and neurodegenerative diseases like Alzheimer's, scientists have found.